Dutch Medical Food B.V., a leading global provider of medical nutrition based in the Netherlands, has announced its entry into the Indian market through a strategic partnership with Pristine Pearl Pharma Pvt. Ltd. This alliance marks the launch of an innovative range of medical nutrition solutions aimed at addressing disease-related malnutrition in both adult and pediatric populations.
The newly launched products target critical conditions such as cancer, pediatric malnutrition, chronic obstructive pulmonary disease (COPD), and drug-resistant epilepsy. With disease-related malnutrition affecting approximately 40% of patients in hospitals and around 25% within the broader community in India, this partnership is poised to have a significant impact. “We are excited to introduce our science-based nutritional solutions to India. This venture transcends business; it is a mission to enhance patient lives,” said Dr. Guru Ramanathan and Dr. Rolf Smeets, co-founders of Dutch Medical Food. “Through our collaboration with Pristine Pearl, we aim to provide doctors with high-quality nutritional support to complement standard treatments, ultimately improving the well-being of patients with chronic conditions.”
Mr. S.M. Ayoob, Managing Director of Pristine Pearl, expressed similar enthusiasm, stating, “Our partnership with Dutch Medical Food aligns with our commitment to improving healthcare outcomes in India. Together, we are dedicated to delivering advanced nutritional solutions that address the pressing needs of patients, ensuring optimal care.”
This strategic collaboration combines Dutch Medical Food’s expertise in innovative nutrition with Pristine Pearl’s established market presence, creating a powerful synergy. The joint efforts of Dutch Medical Food’s teams in Amsterdam and Chennai, alongside Pristine Pearl’s team in Coimbatore, are set to revolutionize patient care by integrating cutting-edge research with compassionate healthcare practices.
